Literature DB >> 11156815

One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype.

B Geller1, J L Craney, K Bolhofner, M P DelBello, M Williams, B Zimerman.   

Abstract

OBJECTIVE: The study examined 1-year recovery and relapse rates for mania in subjects who met criteria for a prepubertal and early adolescent bipolar disorder phenotype.
METHOD: Outpatients identified by consecutive new-case ascertainment were assessed by means of separate child and parent interviews, consensus conferences, and blind best estimates. The definition of the prepubertal and early adolescent bipolar disorder phenotype was DSM-IV mania with elation and/or grandiosity as one criterion.
RESULTS: Of 93 subjects seen at baseline, 89 were seen at 1 year (95.7% retention). The rate of recovery from mania was 37.1%, and the rate of relapse after recovery was 38.3%. No covariates were significantly associated with recovery or relapse.
CONCLUSIONS: The low recovery and high relapse rates supported the study hypothesis of poor outcomes, which was made on the basis of similarity between the characteristics of the prepubertal and early adolescent bipolar disorder phenotype (long episode duration and high prevalence of mixed mania, psychosis, and rapid cycling) and those of severe bipolar disorder in adults.

Entities:  

Mesh:

Year:  2001        PMID: 11156815     DOI: 10.1176/appi.ajp.158.2.303

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  13 in total

1.  Generalizability of evidence-based assessment recommendations for pediatric bipolar disorder.

Authors:  Melissa M Jenkins; Eric A Youngstrom; Jennifer Kogos Youngstrom; Norah C Feeny; Robert L Findling
Journal:  Psychol Assess       Date:  2011-10-17

2.  Family-based interpersonal psychotherapy for depressed preadolescents: an open-treatment trial.

Authors:  Laura J Dietz; Laura Mufson; Holly Irvine; David A Brent
Journal:  Early Interv Psychiatry       Date:  2008-08       Impact factor: 2.732

3.  High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study.

Authors:  Janet Wozniak; Carter R Petty; Meghan Schreck; Alana Moses; Stephen V Faraone; Joseph Biederman
Journal:  J Psychiatr Res       Date:  2011-06-17       Impact factor: 4.791

Review 4.  [Bipolar disorder in childhood and adolescence].

Authors:  Lee Fu-I
Journal:  Braz J Psychiatry       Date:  2004-12-07       Impact factor: 2.697

Review 5.  Management options for bipolar disorder in children and adolescents.

Authors:  Arman Danielyan; Robert A Kowatch
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

6.  Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents.

Authors:  Eric A Youngstrom; Thomas W Frazier; Christine Demeter; Joseph R Calabrese; Robert L Findling
Journal:  J Clin Psychiatry       Date:  2008-05       Impact factor: 4.384

Review 7.  A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder.

Authors:  Megan F Joseph; Thomas W Frazier; Eric A Youngstrom; Jair C Soares
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-12       Impact factor: 2.576

8.  Parental history of substance use disorders (SUD) and SUD in offspring: a controlled family study of bipolar disorder.

Authors:  Timothy E Wilens; Amy Yule; MaryKate Martelon; Courtney Zulauf; Stephen V Faraone
Journal:  Am J Addict       Date:  2014-03-15

Review 9.  Defining and identifying early onset bipolar spectrum disorder.

Authors:  Colleen A Quinn; Mary A Fristad
Journal:  Curr Psychiatry Rep       Date:  2004-04       Impact factor: 5.285

10.  Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children.

Authors:  Eric Mick; Janet Wozniak; Timothy E Wilens; Joseph Biederman; Stephen V Faraone
Journal:  BMC Psychiatry       Date:  2009-02-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.